Preclinical CRO Market Report to Grow at a Stellar Pace Reflecting a 8.14% CAGR, is Set to Reach USD 5,234.7 million By 2024-End, Analysis by Market Research Future

Ads

You May Also Like

Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a ...

uniQure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Jan. 25, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), ...

TESARO Announces Data Presentations at the 2018 American Association for Cancer Research Annual Meeting

WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...